Sumitomo to Reinforce Restructuring to Fight Deficit, First in North America: President

Sumitomo Pharma President Hiroshi Nomura In a bid to stem widening losses, Sumitomo Pharma intends to seek further efficiency in its business operations starting in North America, where it grapples with the patent cliff of its once-high-flying antipsychotic agent Latuda...read more